Long pages
Jump to navigation
Jump to search
Showing below up to 50 results in range #53,801 to #53,850.
- (hist) Sandbox Cardiovascular Drugs2/Diuretics [3,568 bytes]
- (hist) Sandbox Cardiovascular Drugs2/Cardiac Stimulants [3,568 bytes]
- (hist) Sandbox Cardiovascular Drugs2/Calcium Channel Blockers [3,568 bytes]
- (hist) Sandbox Cardiovascular Drugs2/Beta Blockers [3,568 bytes]
- (hist) Sandbox Cardiovascular Drugs2/Antithrombotics [3,568 bytes]
- (hist) Sandbox Cardiovascular Drugs2/Antihypertensives [3,568 bytes]
- (hist) Sandbox Cardiovascular Drugs2/Antiarrhythmics [3,568 bytes]
- (hist) Chorioamnionitis natural history, complications and prognosis [3,568 bytes]
- (hist) Osteomyelitis history and symptoms [3,568 bytes]
- (hist) Premature birth medical therapy [3,568 bytes]
- (hist) Solid-state laser [3,568 bytes]
- (hist) SH3 domain [3,568 bytes]
- (hist) P2RY8 [3,568 bytes]
- (hist) Hexabromocyclododecane [3,568 bytes]
- (hist) Acyl-CoA:lysocardiolipin acyltransferase-1 [3,567 bytes]
- (hist) C1orf21 [3,567 bytes]
- (hist) Toxic shock syndrome natural history, complications and prognosis [3,567 bytes]
- (hist) Budd-Chiari syndrome laboratory findings [3,567 bytes]
- (hist) Down syndrome natural history, complications and prognosis [3,567 bytes]
- (hist) Ichthyosis vulgaris (patient information) [3,567 bytes]
- (hist) TaqMan [3,567 bytes]
- (hist) Leper Chapel, Cambridge [3,567 bytes]
- (hist) Jakob Segal [3,567 bytes]
- (hist) Carbomer [3,567 bytes]
- (hist) Glenn Dale Hospital [3,567 bytes]
- (hist) Granulomatosis with polyangiitis diagnostic study of choice [3,566 bytes]
- (hist) Non small cell lung cancer [3,566 bytes]
- (hist) Aclarubicin [3,566 bytes]
- (hist) African trypanosomiasis epidemiology and demographics [3,566 bytes]
- (hist) Audism [3,566 bytes]
- (hist) Depressive realism [3,566 bytes]
- (hist) Khyber Medical College [3,566 bytes]
- (hist) Benzoylecgonine [3,566 bytes]
- (hist) Chromate [3,566 bytes]
- (hist) Complement membrane attack complex [3,566 bytes]
- (hist) C4 glomerulopathy other diagnostic studies [3,565 bytes]
- (hist) Nitazoxanide adverse reactions [3,565 bytes]
- (hist) Shock laboratory findings [3,565 bytes]
- (hist) TRANSCEND Study suggests that telmisartan reduces cardiovascular events [3,565 bytes]
- (hist) Lansoprazole drug interactions [3,565 bytes]
- (hist) Indium(III) chloride [3,565 bytes]
- (hist) Clark Leonard Hull [3,565 bytes]
- (hist) TRNA (uracil-5-)-methyltransferase [3,565 bytes]
- (hist) The Living Guidelines: Recommendations for Monitoring of symptoms and anti anginal therapy during follow up Polling Results for CLASS IIb Guidelines [3,565 bytes]
- (hist) Fucus serratus [3,565 bytes]
- (hist) Nicosan [3,565 bytes]
- (hist) Ethocybin [3,565 bytes]
- (hist) Sox2 [3,565 bytes]
- (hist) Chronic pancreatitis diagnostic criteria [3,564 bytes]
- (hist) HDGFRP3 [3,564 bytes]